Travel Vaccines Market Insights, Forecast to 2025


Vaccines are a combination of killed microorganisms, living attenuated organisms or living fully virulent organisms that are monitored for artificially increasing or creating immunity for any particular disease. The branch of medicine that deals with the prevention and management of health problems of international travellers is called Emporiatrics. Travel vaccine is the first step towards smart and healthy travel. Nowadays along with the passport, travel vaccine shots are a must have before a person embarks on international travel. Travel vaccines provide immunisation by reducing the risk of getting sick while travelling abroad. Tourists traveling to South America and central countries of Africa should get vaccinated for Yellow Fever. Likewise, different countries have different diseases existing or prevailing within the region. Travel vaccines are recommended by health organisations especially to tourists who travel to developing or endemic countries. DUKORAL is an example of a travel vaccine that protects tourists from Diarrhea and Cholera. These are the common diseases caused by intake of contaminated food and water while travelling. Travel vaccine shot recommendations vary from person to person depending on gender, age and medical history of the tourist.

As the world continues to move toward globalization, the international travels is expected to keep increasing. This fuels the demand for travel vaccines as the prevalence of infectious diseases are specifically region prone, unlike that of other indications. As vaccines are largely used as a preventive measure against these known infectious diseases, the travelers are advised to follow the region-specific immunization plan.

The Americas was the highest revenue contributing region in the market during 2017 and is expected to continue to lead the market in the coming years. The US was one of the highest revenue contributor in the region, capturing a significant portion of the global market. The increasing demand for vaccines that cater to the unmet medical needs provides an opportunity for vendors to develop new safe and efficient molecules, which will aid in the growth of this market in the region.

The global Travel Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Travel Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Travel Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Travel Vaccines in these regions.

This research report categorizes the global Travel Vaccines market by top players/brands, region, type and end user. This report also studies the global Travel Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

  • Pfizer
  • Sanofi
  • GlaxoSmithKline
  • Merck
  • AstraZeneca
  • Abbott
  • Roche
  • Takeda Pharmaceutical
  • Valeant Pharmaceuticals
  • SK Chemicals
  • Hualan Biological Engineering
  • Serum Institute of India

Market size by Product

  • Meningococcal Vaccines
  • Hepatitis B Vaccines
  • Hepatitis A Vaccines
  • Others

Market size by End User

  • Domestic Travel
  • Outbound Travel

Market size by Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Central & South America
  • Brazil
  • Rest of Central & South America
  • Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa

The study objectives of this report are:

  • To study and analyze the global Travel Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
  • To understand the structure of Travel Vaccines market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Travel Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
  • To project the value and sales volume of Travel Vaccines submarkets, with respect to key regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Travel Vaccines are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Travel Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of content

1 Study Coverage
1.1 Travel Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Travel Vaccines Market Size Growth Rate by Product
1.4.2 Meningococcal Vaccines
1.4.3 Hepatitis B Vaccines
1.4.4 Hepatitis A Vaccines
1.4.5 Others
1.5 Market by End User
1.5.1 Global Travel Vaccines Market Size Growth Rate by End User
1.5.2 Domestic Travel
1.5.3 Outbound Travel
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Travel Vaccines Market Size
2.1.1 Global Travel Vaccines Revenue 2014-2025
2.1.2 Global Travel Vaccines Sales 2014-2025
2.2 Travel Vaccines Growth Rate by Regions
2.2.1 Global Travel Vaccines Sales by Regions
2.2.2 Global Travel Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Travel Vaccines Sales by Manufacturers
3.1.1 Travel Vaccines Sales by Manufacturers
3.1.2 Travel Vaccines Sales Market Share by Manufacturers
3.1.3 Global Travel Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Travel Vaccines Revenue by Manufacturers
3.2.1 Travel Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Travel Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Travel Vaccines Price by Manufacturers
3.4 Travel Vaccines Manufacturing Base Distribution, Pro

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414

Follow Us On linkedin :-


Please enter your comment!
Please enter your name here